Published in Int J Mol Sci on March 14, 2016
Extracellular vesicles shed by melanoma cells contain a modified form of H1.0 linker histone and H1.0 mRNA-binding proteins. Int J Oncol (2016) 0.75
NAFLD: Is There Anything New under the Sun? Int J Mol Sci (2017) 0.75
Non-alcoholic fatty liver disease: An expanded review. World J Hepatol (2017) 0.75
Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. Redox Biol (2017) 0.75
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res (2004) 6.98
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol (2015) 4.08
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology (2012) 3.94
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology (2011) 3.70
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol (2006) 3.46
Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology (2011) 2.90
The nature and significance of platelet products in human plasma. Br J Haematol (1967) 2.84
Trafficking and function of the tetraspanin CD63. Exp Cell Res (2008) 2.64
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol (2014) 2.17
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia (2007) 1.97
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol (2013) 1.88
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol (2013) 1.84
Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol (2015) 1.80
Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci U S A (2001) 1.76
Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology (2010) 1.60
The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene (2004) 1.56
Plasma microparticles and vascular disorders. Br J Haematol (2007) 1.52
Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes Cancer (2013) 1.47
PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. Atherosclerosis (2011) 1.44
Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis (2010) 1.42
Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem (2012) 1.40
The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost (2010) 1.40
Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol (2010) 1.37
A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet. Diabetes (2006) 1.36
Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio (2014) 1.34
Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology (2009) 1.33
Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One (2014) 1.31
Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) (2012) 1.31
Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One (2012) 1.28
Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells (2012) 1.23
Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology (2010) 1.20
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev (2012) 1.18
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol (2011) 1.16
Get on the exosome bus with ALIX. Nat Cell Biol (2012) 1.16
Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology (2014) 1.16
Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res (2006) 1.14
Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost (2009) 1.14
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int (2013) 1.13
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology (2013) 1.11
Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Sci Signal (2013) 1.08
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol (2014) 1.08
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br J Cancer (2015) 1.07
Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology (2012) 1.06
Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep (2015) 1.04
Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int (2014) 1.01
The emerging roles of microvesicles in liver diseases. Nat Rev Gastroenterol Hepatol (2014) 1.01
Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev (2014) 1.00
The liver sieve and atherosclerosis. Pathology (2012) 1.00
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. J Diabetes Investig (2013) 0.99
Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Int J Clin Exp Pathol (2013) 0.97
Circulating procoagulant microparticles in obesity. Diabetes Metab (2006) 0.97
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Curr Diab Rep (2007) 0.95
Dynamics of circulating microparticles in liver transplant patients. J Gastrointestin Liver Dis (2008) 0.95
Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles. J Natl Cancer Inst (1975) 0.92
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.92
Exosomes mediate intercellular transfer of pro-fibrogenic connective tissue growth factor (CCN2) between hepatic stellate cells, the principal fibrotic cells in the liver. Surgery (2014) 0.92
Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. J Hepatol (2014) 0.91
Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS One (2013) 0.91
Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr Res (2014) 0.90
Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacol Sin (2014) 0.90
microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int (2014) 0.89
Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells. J Transl Med (2014) 0.88
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis (2015) 0.88
Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma. Dis Markers (2015) 0.88
Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Clin Chim Acta (2015) 0.87
Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab (2013) 0.86
Microparticles: Modulators and biomarkers of liver disease. J Hepatol (2012) 0.86
Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion (2008) 0.85
Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. J Proteome Res (2015) 0.85
Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals. Int J Nanomedicine (2014) 0.84
Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. J Surg Res (2014) 0.84
Liver extracellular vesicles in health and disease. J Extracell Vesicles (2012) 0.83
Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. Obes Surg (2007) 0.83
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. BMC Cancer (2014) 0.83
Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells. Eur J Med Res (2013) 0.82
Differential roles of tissue factor and phosphatidylserine in activation of coagulation. Thromb Res (2014) 0.82
Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets (2009) 0.82
MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma. Acta Gastroenterol Belg (2013) 0.81
Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells. Obesity (Silver Spring) (2014) 0.81
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS One (2014) 0.80
Investigation of the roles of exosomes in colorectal cancer liver metastasis. Oncol Rep (2015) 0.80
Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN. PLoS One (2013) 0.80
Circulating CD147 predicts mortality in advanced hepatocellular carcinoma. J Gastroenterol Hepatol (2016) 0.78
Sampling variability of transient elastography according to probe location. Eur J Gastroenterol Hepatol (2011) 0.78
Platelet activation in patients with alcoholic liver disease. Tokai J Exp Clin Med (2005) 0.77
Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int (2015) 0.77
Statins and nonalcoholic fatty liver disease: a bright future? Expert Opin Investig Drugs (2013) 0.76
Comparison of microRNA expression profiles in HCC-derived microvesicles and the parental cells and evaluation of their roles in HCC. J Huazhong Univ Sci Technolog Med Sci (2013) 0.76
Characterization of microparticles after hepatic ischemia-reperfusion injury. PLoS One (2014) 0.76
Biodegradable microspheres. VII: Alterations in mouse liver morphology after intravenous administration of polyacryl starch microparticles with different biodegradability. J Pharm Sci (1988) 0.75